New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
07:13 EDTNNVCNanoViricides signs confidential disclosure agreement with Viroclinics
NanoViricides has signed a “confidential disclosure agreement" with Viroclinics Biosciences, BV, a spinoff of the Department of Viroscience at the Erasmus Medical Centre in Rotterdam, the Netherlands. The agreement will allow the scientists at Viroclinics to develop a specific proposal for the testing of different nanoviricides , such as FluCide, against viruses of mutual interest to both organizations.
News For NNVC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 17, 2014
07:05 EDTNNVCNanoViricides says all drug development programs progressing satisfactorily
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use